According to Gehlken et al, Galectin-3 is highly stable and resistant to hemodynamic alterations, and is an early indicator of cardiac fibrosis, inflammation, ventricular remodeling, and renal impairment in HF patients; however, it has low specificity [41,42]. The gene discussed is LGALS3; the disease is hydrops fetalis.